Autoimmune disease = a condition has to result from an attack of B & T cells.
Autoimmune diseases are multifactorial and chronic, and the term encompasses nearly 100 different conditions (9). They are characterized by an immune system that erroneously attacks healthy host cells; examples include Multiple sclerosis (MS), Type 1 Diabetes (T1D), rheumatoid arthritis, systemic lupus erythematosus (SLE) and Inflammatory Bowel Disease (IBD) (1).
Typically, patients with autoimmune disease exhibit decreased abundances of tolerogenic Interleukin-10 (IL-10)-producing CD4+ CD25+ FOXP3 high Treg (peripherally induced) and an increased abundance of autoreactive, effector T cell subsets such as CD4+ Th1 Cells and CD4+ Th17 cells, which shift the ratio of Treg cells to effector T cells away from a homeostatic state level (2).
During the past century, the incidence of autoimmune diseases has overtaken that of infectious diseases in industrialized countries (3)
Although there appears to be some genetic component, studies of disease discordant twins have found that concordance rates are incomplete and, therefore, environmental factors, including the gut microbiome, likely contribute to disease development (4, 5). MHC-ll strongly correlates to most autoimmune disease (10).
Factors prominent in northern populations - circadian rhythm disruption and vitamin D deficiencies— have also resulted in immune dysregulation via shifts in gut microbiota, leading to autoimmune diseases like Type 1 Diabetes (T1D) (6, 7, 8).
With a few exceptions (e.g., Sardinia, Italy), autoimmune disease incidence follows a north-south trajectory, with higher incidences in Nordic countries, such as Finland, Sweden, and Norway (11, 12).
(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
(11)
(12)